Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): a state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

The guidelines for classification, prognostication, and response assessment of myelodysplastic syndromes/neoplasms (MDS) have all recently been updated. In this report on behalf of the International Consortium for MDS (icMDS) we summarize these developments. We first critically examine the updated W...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Stahl, M, Bewersdorf, JP, Xie, Z, Porta, MGD, Komrokji, R, Xu, ML, Abdel-Wahab, O, Taylor, J, Steensma, DP, Starczynowski, DT, Sekeres, MA, Sanz, G, Sallman, DA, Roboz, GJ, Platzbecker, U, Patnaik, MM, Padron, E, Odenike, O, Nimer, SD, Nazha, A, Majeti, R, Loghavi, S, Little, RF, List, AF, Kim, TK, Hourigan, CS, Hasserjian, RP, Halene, S, Griffiths, EA, Gore, SD, Greenberg, P, Figueroa, ME, Fenaux, P, Efficace, F, DeZern, AE, Daver, NG, Churpek, JE, Carraway, HE, Buckstein, R, Brunner, AM, Boultwood, J, Borate, U, Bejar, R, Bennett, JM, Wei, AH, Santini, V, Savona, MR, Zeidan, AM
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	Elsevier 2023

Eitemau Tebyg

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
gan: Efficace, F, et al.
Cyhoeddwyd: (2024)

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
gan: Fabio Efficace, et al.
Cyhoeddwyd: (2024-05-01)

S170: MYELODYSPLASTIC NEOPLASMS (MDS) CLASSIFICATION FROM WHO 2017 TO WHO 2022 AND ICC 2022): AN EXPANDED ANALYSIS OF 7017 PATIENTS ON BEHALF OF THE INTERNATIONAL CONSORTIUM FOR MDS (ICMDS)
gan: Rami S. Komrokji, et al.
Cyhoeddwyd: (2023-08-01)

Generalized GM-MDS: Polynomial Codes Are Higher Order MDS
gan: Brakensiek, Joshua, et al.
Cyhoeddwyd: (2024)

The weights in MDS codes
gan: Ezerman, Martianus Frederic, et al.
Cyhoeddwyd: (2019)

Construction of MDS matrices
gan: Peng-fei LI, et al.
Cyhoeddwyd: (2016-06-01)

Application of classical Hermitian self-orthogonal MDS codes to quantum MDS codes
gan: Jin, Lingfei, et al.
Cyhoeddwyd: (2012)

PB1999: TOBACCO SMOKING IN MDS PATIENTS – ANALYSIS FROM THE MDS PALG REGISTRY
gan: Rafal Machowicz, et al.
Cyhoeddwyd: (2023-08-01)

THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (t-MDS) IN CHILDHOOD: THE EXPERIENCE OF THE HELLENIC STUDY GROUP FOR MDS/JMML/SAA, MEMBER OF THE EWOG-MDS/SAA WORKING GROUP
gan: Loizos Petrikkos, et al.
Cyhoeddwyd: (2023-12-01)

New quantum MDS codes
gan: Zhang, Guanghui, et al.
Cyhoeddwyd: (2015)

Inherited predisposition to MDS/AML
gan: Ana Rio Machin, et al.
Cyhoeddwyd: (2018-06-01)

The impact of spliceosome mutations in MDS
gan: Jacqueline Boultwood, et al.
Cyhoeddwyd: (2019-06-01)

MDS-482 Impact of magrolimab in combination with azacitidine on red blood cells (RBCs) in patients with higher-risk myelodysplastic syndromes (HR MDS)
gan: Chen, J, et al.
Cyhoeddwyd: (2022)

P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY
gan: F. Schulz, et al.
Cyhoeddwyd: (2022-06-01)

MDS plus data acquisition system
gan: Stillerman, J.A., et al.
Cyhoeddwyd: (2015)

Diffusion analysis of EFN-MDS structure
gan: Ibrahim, Subariah
Cyhoeddwyd: (2006)

Diffusion analysis of EFN-MDS structure
gan: Ibrahim, Subariah, et al.
Cyhoeddwyd: (2006)

The role of innate immunity in MDS pathogenesis
gan: David A. Sallman, et al.
Cyhoeddwyd: (2019-06-01)

High-risk MDS after HMAs
gan: Lionel Adès
Cyhoeddwyd: (2019-06-01)

P743: THE PIVOTAL ROLE OF GLUTAMINOLYSIS IN MYELODYSPLASTIC SYNDROME (MDS): A NOVEL STRATEGY FOR THE TARGETED THERAPY OF MDS
gan: S. Okabe, et al.
Cyhoeddwyd: (2022-06-01)

IMPLICATIONS OF NOVEL CLASSIFICATIONS OF MYELOID NEOPLASMS FOR CHILDHOOD MDS
gan: Katherine R. Calvo
Cyhoeddwyd: (2023-12-01)

DHPLC analysis of the ATRX gene in myelodysplastic syndrome (MDS) associated with acquired alpha thalassemia (AT-MDS): Novel mutation detection despite somatic mosaicism.
gan: Steensma, D, et al.
Cyhoeddwyd: (2003)

Integrated genetic, epigenetic, and immune landscape of mutant AML and higher risk MDS treated with azacitidine
gan: Amer M. Zeidan, et al.
Cyhoeddwyd: (2024-06-01)

Application of constacyclic codes to quantum MDS codes
gan: Chen, Bocong, et al.
Cyhoeddwyd: (2015)

A construction of MDS quantum convolutional codes
gan: Zhang, Guanghui, et al.
Cyhoeddwyd: (2015)

Trisomy X and myelodysplastic syndrome (MDS) with eosinophilia
gan: Mohd Tohit, Eusni Rahayu, et al.
Cyhoeddwyd: (2012)

On linear codes whose hermitian hulls are MDS
gan: Luo, Gaojun, et al.
Cyhoeddwyd: (2024)

HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
gan: Mazyar Shadman, et al.
Cyhoeddwyd: (2014-09-01)

Value-based adoption of MDS:an empirical investigation
gan: ZHOU Yi1, et al.
Cyhoeddwyd: (2008-01-01)

Editorial: MDS: new scientific and clinical developments
gan: Sabine Blum, et al.
Cyhoeddwyd: (2025-02-01)

Value-based adoption of MDS:an empirical investigation
gan: ZHOU Yi1, et al.
Cyhoeddwyd: (2008-01-01)

Understanding iron homeostasis in MDS: the role of erythroferrone
gan: Mohammed L. Abba, et al.
Cyhoeddwyd: (2024-05-01)

Controversies on the Consequences of Iron Overload and Chelation in MDS
gan: Francesca Vinchi, et al.
Cyhoeddwyd: (2020-06-01)

Recent advances in MDS mutation landscape: splicing and signalling
gan: Follo, MY, et al.
Cyhoeddwyd: (2019)

Novel dynamic outcome indicators and clinical endpoints in myelodysplastic syndrome; the European LeukemiaNet MDS Registry and MDS-RIGHT project perspective
gan: Theo de Witte, et al.
Cyhoeddwyd: (2020-09-01)

P703: THE AIPSS-MDS MACHINE LEARNING MODEL PREDICTS OVERALL SURVIVAL AND LEUKEMIC TRANSFORMATION IN CMML: AN ANALYSIS OF THE SPANISH REGISTRY OF MDS
gan: Adrian Mosquera-Orgueira, et al.
Cyhoeddwyd: (2023-08-01)

SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
gan: Malcovati, L, et al.
Cyhoeddwyd: (2020)

PB1921: A RANDOMIZED, DOUBLE-BLIND, PHASE 3 STUDY OF TAMIBAROTENE/AZACITIDINE VERSUS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS (SELECT-MDS-1)
gan: A. DeZern, et al.
Cyhoeddwyd: (2022-06-01)

New Systematic MDS Array Codes With Two Parities
gan: Lan Ma, et al.
Cyhoeddwyd: (2024-01-01)

MDS CODEC EVALUATION BASED ON PERCEPTUAL SOUND ATTRIBUTES
gan: Marcelo Herrera Martínez, et al.
Cyhoeddwyd: (2014-12-01)